KDM1 is a novel therapeutic target for the treatment of gliomas

Glioma development is a multistep process, involving alterations in genetic and epigenetic mechanisms. Understanding the mechanisms and enzymes that promote epigenetic changes in gliomas are urgently needed to identify novel therapeutic targets. We examined the role of histone demethylase KDM1 in gl...

Descripción completa

Detalles Bibliográficos
Autores principales: Sareddy, Gangadhara R., Nair, Binoj C., Krishnan, Samaya K., Gonugunta, Vijay K., Zhang, Quan-guang, Suzuki, Takayoshi, Miyata, Naoki, Brenner, Andrew J., Brann, Darrell W., Vadlamudi, Ratna K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2012
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702204/
https://www.ncbi.nlm.nih.gov/pubmed/23248157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702204/
https://www.ncbi.nlm.nih.gov/pubmed/23248157

Ejemplares similares